Niagen Bioscience
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NAGE and other ETFs, options, and stocks.About NAGE
Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+).
NAGE Key Statistics
Stock Snapshot
The current Niagen Bioscience(NAGE) stock price is $5.09, with a market capitalization of 408.41M. The stock trades at a price-to-earnings (P/E) ratio of 24.88.
As of 2026-03-09, Niagen Bioscience(NAGE) stock has fluctuated between $4.80 and $5.28. The current price stands at $5.09, placing the stock +6.0% above today's low and -3.6% off the high.
Niagen Bioscience(NAGE) shares are trading with a volume of 2.79M, against a daily average of 2.36M.
In the last year, Niagen Bioscience(NAGE) shares hit a 52-week high of $14.69 and a 52-week low of $4.73.
In the last year, Niagen Bioscience(NAGE) shares hit a 52-week high of $14.69 and a 52-week low of $4.73.
NAGE News
ChromaDex Corporation ((NAGE)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 70% Off TipRanks Premium Unlock hedge fund-leve...
Niagen Bioscience recently reported its strongest year to date, with 2025 net sales reaching US$129.4 million, net income of US$17.4 million, and management gui...
Niagen Bioscience (NAGE) is back in focus after reporting strong 2025 revenue and profit growth that exceeded its own guidance, while also laying out moderated...
Analyst ratings
100%
of 6 ratingsMore NAGE News
Canaccord analyst Susan Anderson lowered the firm’s price target on Niagen Bioscience (NAGE) to $13 from $14 and keeps a Buy rating on the shares. The firm upda...
Niagen Bioscience Inc. (NASDAQ:NAGE) jumped 18.41% in after-hours trading on Wednesday to $5.85. Shares of the Los Angeles-based biotechnology company closed t...
Earnings Call Insights Niagen Bioscience targets 10–15% revenue growth for 2026 while expanding injectable product line Mar. 04, 2026 7:12 PM ET Niagen Bioscien...
Niagen Bioscience ( (NAGE) ) just unveiled an update. Niagen Bioscience reported on March 4, 2026 that 2025 net sales rose 30% year over year to $129.4 million...
Niagen Bioscience (NASDAQ:NAGE) , whose anti-aging product counts longevity entrepreneur Bryan Johnson among its customers, reported its strongest financial res...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.